Although a previous study found that peripheral QUIN was in patients with SCH [30], a systematic review inferred that there was no significant increase in QUIN and PIC, and peripheral blood levels of tryptophan catabolites were dissociated from central nervous system findings except for a modest increase in the serum IDO activity of patients with SCH [31]. The gene discussed is IDO1; the disease is spindle cell hemangioma.